Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Fleckenstein

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Synapse (New York, N.Y.)|July 30, 2013
The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrationsLisa M McFadden, Glen R Hanson, Annette E Fleckenstein
European Journal of Pharmacology|June 5, 2004
Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegenerationJannine G Truong, Glen R Hanson, Annette E Fleckenstein
Neuropharmacology|October 7, 2004
The methamphetamine experience: a NIDA partnershipGlen R Hanson, Kristi S Rau, Annette E Fleckenstein
Addiction (Abingdon, England)|May 12, 2007
Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatmentTrent J Volz, Annette E Fleckenstein, Glen R Hanson
Annals of the New York Academy of Sciences|November 16, 2004
Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implicationsGlen R Hanson, Veronica Sandoval, Evan Riddle, et al.
European Journal of Pharmacology|December 9, 2003
The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicityKamisha L Johnson-Davis, Annette E Fleckenstein, Diana G Wilkins
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2002
Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptorsVerónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficitsVerónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2008
Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activationSarah J Farnsworth, Trent J Volz, Glen R Hanson, et al.
European Journal of Pharmacology|October 28, 2004
Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 proteinJannine G Truong, Amy H Newman, Glen R Hanson, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Synapse (New York, N.Y.)|July 30, 2013
The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrationsLisa M McFadden, Glen R Hanson, Annette E Fleckenstein
European Journal of Pharmacology|June 5, 2004
Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegenerationJannine G Truong, Glen R Hanson, Annette E Fleckenstein
Neuropharmacology|October 7, 2004
The methamphetamine experience: a NIDA partnershipGlen R Hanson, Kristi S Rau, Annette E Fleckenstein
Addiction (Abingdon, England)|May 12, 2007
Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatmentTrent J Volz, Annette E Fleckenstein, Glen R Hanson
Annals of the New York Academy of Sciences|November 16, 2004
Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implicationsGlen R Hanson, Veronica Sandoval, Evan Riddle, et al.
European Journal of Pharmacology|December 9, 2003
The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicityKamisha L Johnson-Davis, Annette E Fleckenstein, Diana G Wilkins
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2002
Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptorsVerónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficitsVerónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 29, 2008
Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activationSarah J Farnsworth, Trent J Volz, Glen R Hanson, et al.
European Journal of Pharmacology|October 28, 2004
Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 proteinJannine G Truong, Amy H Newman, Glen R Hanson, et al.
Pageof 8